CDR-Life is a biopharmaceutical company that redefines antibody therapies. It develops novel therapeutics, aiming to transform the lives of people with sight- and life-threatening diseases, based on a technology for composing modular antibodies with ideal pharmacological and drug-like properties.

Products, services, technology

CDR-Life’s lead programs include novel immunotherapies that target intracellular cancer-related proteins for superior tumor-selectivity and more durable efficacy. The company’s portfolio contains several first-in-class immunotherapies against solid and liquid tumors.

Cooperation possibilities

CDR-Life has a strategic partnership with a global pharmaceutical company and continues to partner with leading companies that share our vision of bringing its highly innovative antibody therapies to patients.

Location

Wagistrasse 27, 8952 Schlieren, Switzerland

Facts & figures
  • Type of organization

    Private company

  • Year of foundation

    2017

  • Number of employees in Switzerland

    20-49

Key business